Cargando…

Development of a deep learning-based error detection system without error dose maps in the patient-specific quality assurance of volumetric modulated arc therapy

To detect errors in patient-specific quality assurance (QA) for volumetric modulated arc therapy (VMAT), we proposed an error detection method based on dose distribution analysis using unsupervised deep learning approach and analyzed 161 prostate VMAT beams measured with a cylindrical detector. For...

Descripción completa

Detalles Bibliográficos
Autores principales: Kimura, Yuto, Kadoya, Noriyuki, Oku, Yohei, Jingu, Keiichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354858/
https://www.ncbi.nlm.nih.gov/pubmed/37177789
http://dx.doi.org/10.1093/jrr/rrad028
_version_ 1785075010992340992
author Kimura, Yuto
Kadoya, Noriyuki
Oku, Yohei
Jingu, Keiichi
author_facet Kimura, Yuto
Kadoya, Noriyuki
Oku, Yohei
Jingu, Keiichi
author_sort Kimura, Yuto
collection PubMed
description To detect errors in patient-specific quality assurance (QA) for volumetric modulated arc therapy (VMAT), we proposed an error detection method based on dose distribution analysis using unsupervised deep learning approach and analyzed 161 prostate VMAT beams measured with a cylindrical detector. For performing error simulation, in addition to error-free dose distribution, dose distributions containing nine types of error, including multileaf collimator (MLC) positional errors, gantry rotation errors, radiation output errors and phantom setup errors, were generated. Only error-free data were employed for the model training, and error-free and error data were employed for the tests. As a deep learning model, the variational autoencoder (VAE) was adopted. The anomaly of test data was quantified by calculating Mahalanobis distance based on the feature vectors acquired from a trained encoder. Based on this anomaly, test data were classified as ‘error-free’ or ‘any-error.’ For comparison with conventional approaches, gamma (γ)-analysis was performed, and supervised learning convolutional neural network (S-CNN) was constructed. Receiver operating characteristic curves were obtained to evaluate their performance with the area under the curve (AUC). For all error types, except systematic MLC positional and radiation output errors, the performance of the methods was in the order of S-CNN ˃ VAE-based ˃ γ-analysis (only S-CNN required error data for model training). For example, in random MLC positional error simulation, the AUC of our method, S-CNN and γ-analysis were 0.699, 0.921 and 0.669, respectively. Our results showed that the VAE-based method has the potential to detect errors in patient-specific VMAT QA.
format Online
Article
Text
id pubmed-10354858
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-103548582023-07-20 Development of a deep learning-based error detection system without error dose maps in the patient-specific quality assurance of volumetric modulated arc therapy Kimura, Yuto Kadoya, Noriyuki Oku, Yohei Jingu, Keiichi J Radiat Res Regular paper To detect errors in patient-specific quality assurance (QA) for volumetric modulated arc therapy (VMAT), we proposed an error detection method based on dose distribution analysis using unsupervised deep learning approach and analyzed 161 prostate VMAT beams measured with a cylindrical detector. For performing error simulation, in addition to error-free dose distribution, dose distributions containing nine types of error, including multileaf collimator (MLC) positional errors, gantry rotation errors, radiation output errors and phantom setup errors, were generated. Only error-free data were employed for the model training, and error-free and error data were employed for the tests. As a deep learning model, the variational autoencoder (VAE) was adopted. The anomaly of test data was quantified by calculating Mahalanobis distance based on the feature vectors acquired from a trained encoder. Based on this anomaly, test data were classified as ‘error-free’ or ‘any-error.’ For comparison with conventional approaches, gamma (γ)-analysis was performed, and supervised learning convolutional neural network (S-CNN) was constructed. Receiver operating characteristic curves were obtained to evaluate their performance with the area under the curve (AUC). For all error types, except systematic MLC positional and radiation output errors, the performance of the methods was in the order of S-CNN ˃ VAE-based ˃ γ-analysis (only S-CNN required error data for model training). For example, in random MLC positional error simulation, the AUC of our method, S-CNN and γ-analysis were 0.699, 0.921 and 0.669, respectively. Our results showed that the VAE-based method has the potential to detect errors in patient-specific VMAT QA. Oxford University Press 2023-05-12 /pmc/articles/PMC10354858/ /pubmed/37177789 http://dx.doi.org/10.1093/jrr/rrad028 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of The Japanese Radiation Research Society and Japanese Society for Radiation Oncology. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Regular paper
Kimura, Yuto
Kadoya, Noriyuki
Oku, Yohei
Jingu, Keiichi
Development of a deep learning-based error detection system without error dose maps in the patient-specific quality assurance of volumetric modulated arc therapy
title Development of a deep learning-based error detection system without error dose maps in the patient-specific quality assurance of volumetric modulated arc therapy
title_full Development of a deep learning-based error detection system without error dose maps in the patient-specific quality assurance of volumetric modulated arc therapy
title_fullStr Development of a deep learning-based error detection system without error dose maps in the patient-specific quality assurance of volumetric modulated arc therapy
title_full_unstemmed Development of a deep learning-based error detection system without error dose maps in the patient-specific quality assurance of volumetric modulated arc therapy
title_short Development of a deep learning-based error detection system without error dose maps in the patient-specific quality assurance of volumetric modulated arc therapy
title_sort development of a deep learning-based error detection system without error dose maps in the patient-specific quality assurance of volumetric modulated arc therapy
topic Regular paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354858/
https://www.ncbi.nlm.nih.gov/pubmed/37177789
http://dx.doi.org/10.1093/jrr/rrad028
work_keys_str_mv AT kimurayuto developmentofadeeplearningbasederrordetectionsystemwithouterrordosemapsinthepatientspecificqualityassuranceofvolumetricmodulatedarctherapy
AT kadoyanoriyuki developmentofadeeplearningbasederrordetectionsystemwithouterrordosemapsinthepatientspecificqualityassuranceofvolumetricmodulatedarctherapy
AT okuyohei developmentofadeeplearningbasederrordetectionsystemwithouterrordosemapsinthepatientspecificqualityassuranceofvolumetricmodulatedarctherapy
AT jingukeiichi developmentofadeeplearningbasederrordetectionsystemwithouterrordosemapsinthepatientspecificqualityassuranceofvolumetricmodulatedarctherapy